Padlock Therapeutics
AcquiredCambridge, United States · Founded 2014 · $23.0M raised
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2014
- Business Model
- B2B
- Total Funding
- $23.0M
- Last Round
- $23.0M Series ADec 2014
- Rounds
- 1
- Acquired by
- Bristol-Myers Squibb CompanyMar 2016 · $35.0M
About
Padlock Therapeutics was a Cambridge, Massachusetts-based biotechnology company founded in 2014 to develop novel small-molecule and biologic medicines targeting protein arginine deiminase (PAD) enzymes implicated in autoimmune diseases such as rheumatoid arthritis and lupus. The company was acquired by Bristol-Myers Squibb in April 2016 for up to $600 million, expanding BMS's autoimmune disease pipeline.
Summary
Padlock Therapeutics is a Biotech company based in Cambridge, United States, founded in 2014. It has raised $23.0M in total across 1 round, most recently a $23.0M Series A round in Dec 2014. Investors include Bristol Myers Squibb and Atlas Venture.
Funding History
Mar 2016
Sign up to see all 2 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/padlock-therapeutics"><img src="https://indexed.vc/api/badge/company/padlock-therapeutics" alt="Padlock Therapeutics on Indexed.vc" width="260" height="76" /></a>